144 - Akero Therapeutics, Inc. (0001744659) (Subject) | Filings Insight

Akero Therapeutics, Inc.

0001744659 Nasdaq

144 - Akero Therapeutics, Inc. (0001744659) (Subject)[0]

[144]Report of proposed sale of securities(접수일: 2025-08-12)

[SUBJECT COMPANY]Akero Therapeutics, Inc. | [REPORTING-OWNER]Henderson Jane |

/ 0